Home » Headlines » Currently Reading:

Morning Headlines 8/8/14

August 7, 2014 Headlines No Comments

Allscripts announces second quarter 2014 results

Allscripts reports Q2 results: a nine percent increase in quarterly bookings drove revenue up two percent, to $354 million. Adjusted EPS EPS $0.09 vs. $0.05, meeting analyst expectations.

More Than Half of US Hospitals Have At Least A Basic EHR, But Stage 2 Criteria Remain Challenging For Most

A Health Affairs study finds that only 5.8 percent of hospitals are currently able to meet all of the MU Stage 2 criteria.

Walgreens stock smacked after tax inversion out

Walgreens acquires overseas pharmacy chain Alliance Boots in a move many assumed would be followed by a tax-dodging transfer of its headquarters out of country. Instead, Walgreens announced that it would keep its headquarters in the US, leading to a 14 percent drop in its stock price.

Health Information Technology in the United States: Progress and Challenges Ahead, 2014

RWJF publishes a report on the EHR incentive program and the state of EHR adoption across the US.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Ageed Mike, "patients are the widgets that must be processed" additionally when it costs close to $3,700 a month for…

  2. The TSA-ification of every aspect of American society continues at pace. Race to the bottom, and technology amplifies the obvious…

  3. I dont think anything will change until Dr Jayne and others take my approach of naming names, including how much…

  4. My husband was in the ER, upon discharge we were handed discharge papers, after getting home we realized they were…

  5. I love the community health center that serves as my medical home, but they regularly ask me to sign forms…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.